diltiazem hydrochloride 360 mg 24 hr extended release capsule

INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules (Once-a-day dosage) are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules (Once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm.

sun pharmaceutical industries, inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] diarrhoea` `[4] off label use` `[5] drug ineffective` `[6] drug hypersensitivity` `[7] pain` `[8] dyspnoea` `[9] headache` `[10] dizziness`

3 years ago

CAPSULE BLUE 679 679

HOW SUPPLIED

DILTIAZEM HYDROCHLORIDE Extended-Release capsules, USP (Once-a-Day Dosage) Strength Quantity NDC Number Description 120 mg Bottle of 30 CRC Bottle of 90 CRC Bottle of 90 NCRC Bottle of 500 NCRC Bottle of 1000 NCRC 47335-675-83 47335-675-81 47335-675-19 47335-675-13 47335-675-18 Hard gelatin capsules, size ‘2’Light turquoise blue colored cap and body, with “675” imprinted in black ink on cap and body, containing white to off white pellets. 180 mg Bottle of 30 CRC Bottle of 90 CRC Bottle of 90 NCRC Bottle of 500 NCRC Bottle of 1000 NCRC 47335-676-83 47335-676-81 47335-676-19 47335-676-13 47335-676-18 Hard gelatin capsules, size ‘0’ blue colored cap and light turquoise blue body, with “676” imprinted in black ink on cap and body, containing white to off white pellets. 240 mg Bottle of 30 CRC Bottle of 90 CRC Bottle of 90 NCRC Bottle of 500 NCRC Bottle of 1000 NCRC 47335-677-83 47335-677-81 47335-677-19 47335-677-13 47335-677-18 Hard gelatin capsules, size ‘0’ blue colored cap and blue colored body, with “677” imprinted in black ink on cap and body, containing white to off white pellets. 300 mg Bottle of 30 CRC Bottle of 90 CRC Bottle of 90 NCRC Bottle of 500 NCRC Bottle of 1000 NCRC 47335-678-83 47335-678-81 47335-678-19 47335-678-13 47335-678-18 Hard gelatin capsules, size ‘00’ blue colored cap and gray colored body, with “678” imprinted in black ink on cap and body, containing white to off white pellets. 360 mg Bottle of 30 CRC Bottle of 90 CRC Bottle of 90 NCRC Bottle of 500 NCRC Bottle of 1000 NCRC 47335-679-83 47335-679-81 47335-679-19 47335-679-13 47335-679-18 Hard gelatin capsules, size ‘00’ blue colored cap and white colored body with “679” imprinted in black ink on cap and body, containing white to off white pellets. Storage Condition Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Avoid excessive humidity. Dispense in light-resistant, tight container with child-resistant closure.

More pills like CAPSULE 679 679

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

diltiazem hydrochloride 360 mg 24 hr extended release capsule

FDA Reported Adverse Reactions [1] fatigue [2] nausea [3] diarrhoea [4] off label use [5] drug ineffective [6] drug hypersensitivity [7] pain [8] dyspnoea [9] headache [10] dizziness

CAPSULE BLUE 679 679

More pills like CAPSULE 679 679

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] diarrhoea` `[4] off label use` `[5] drug ineffective` `[6] drug hypersensitivity` `[7] pain` `[8] dyspnoea` `[9] headache` `[10] dizziness`